<VariationArchive VariationID="417888" VariationName="NM_004369.4(COL6A3):c.7669-2del" VariationType="Deletion" Accession="VCV000417888" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2017-04-23" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="404758" VariationID="417888">
      <GeneList>
        <Gene Symbol="COL6A3" FullName="collagen type VI alpha 3 chain" GeneID="1293" HGNC_ID="HGNC:2213" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q37.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="237324018" stop="237414164" display_start="237324018" display_stop="237414164" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="238232654" stop="238322849" display_start="238232654" display_stop="238322849" Strand="-" />
          </Location>
          <OMIM>120250</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004369.4(COL6A3):c.7669-2del</Name>
      <CanonicalSPDI>NC_000002.12:237342162:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q37.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="237342163" stop="237342163" display_start="237342163" display_stop="237342163" variantLength="1" positionVCF="237342162" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="238250806" stop="238250806" display_start="238250806" display_stop="238250806" variantLength="1" positionVCF="238250805" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004369.3" sequenceAccession="NM_004369" sequenceVersion="3" change="c.7669-2delA">
            <Expression>NM_004369.3:c.7669-2delA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.238250806del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.238250806del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.237342163del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.237342163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008676.1" sequenceAccession="NG_008676" sequenceVersion="1" change="g.77045del">
            <Expression>NG_008676.1:g.77045del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_057166.5" sequenceAccession="NM_057166" sequenceVersion="5" change="c.5848-2del">
            <Expression>NM_057166.5:c.5848-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_057167.4" sequenceAccession="NM_057167" sequenceVersion="4" change="c.7051-2del">
            <Expression>NM_057167.4:c.7051-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004369.4" sequenceAccession="NM_004369" sequenceVersion="4" change="c.7669-2del" MANESelect="true">
            <Expression>NM_004369.4:c.7669-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_473" sequenceAccession="LRG_473">
            <Expression>LRG_473:g.77045del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2187731" DB="ClinGen" />
        <XRef Type="rs" ID="764193290" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004369.4(COL6A3):c.7669-2del AND multiple conditions" Accession="RCV000477801" Version="1">
        <ClassifiedConditionList TraitSetID="23443">
          <ClassifiedCondition DB="MedGen" ID="CN029274">Bethlem myopathy 1A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4225336">Dystonia 27</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0410179">Ullrich congenital muscular dystrophy 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-02-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004369.4(COL6A3):c.7669-2del AND COL6A3-related disorder" Accession="RCV004551575" Version="1">
        <ClassifiedConditionList TraitSetID="84833">
          <ClassifiedCondition>COL6A3-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-04-23" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <DescriptionHistory Dated="2024-03-14">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="84833" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="67683" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">COL6A3-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">COL6A3-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COL6A3-related disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="23443" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5081" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ullrich congenital muscular dystrophy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ullrich congenital muscular dystrophy 1A</ElementValue>
                <XRef ID="MONDO:0009681" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Late onset scleroatonic familial myopathy (subtype)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">UCMD1A</ElementValue>
                <XRef Type="MIM" ID="254090" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">UCMD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="75840" DB="Orphanet" />
              <XRef ID="C0410179" DB="MedGen" />
              <XRef ID="MONDO:0009681" DB="MONDO" />
              <XRef Type="MIM" ID="254090" DB="OMIM" />
            </Trait>
            <Trait ID="492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bethlem myopathy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myopathy, benign congenital, with contractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bethlem myopathy 1A</ElementValue>
                <XRef ID="MONDO:0024530" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1A</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BTHLM1</ElementValue>
                <XRef Type="MIM" ID="158810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Collagen VI-related dystrophies (COL6-RDs) represent a continuum of overlapping clinical phenotypes with Bethlem muscular dystrophy at the milder end, Ullrich congenital muscular dystrophy (UCMD) at the more severe end, and a phenotype in between UCMD and Bethlem muscular dystrophy, referred to as intermediate COL6-RD. Bethlem muscular dystrophy is characterized by a combination of proximal muscle weakness and joint contractures. Hypotonia and delayed motor milestones occur in early childhood; mild hypotonia and weakness may be present congenitally. By adulthood, there is evidence of proximal weakness and contractures of the elbows, Achilles tendons, and long finger flexors. The progression of weakness is slow, and more than two thirds of affected individuals older than age 50 years remain independently ambulatory indoors, while relying on supportive means for mobility outdoors. Respiratory involvement is not a consistent feature. UCMD is characterized by congenital weakness, hypotonia, proximal joint contractures, and striking hyperlaxity of distal joints. Decreased fetal movements are frequently reported. Some affected children acquire the ability to walk independently; however, progression of the disease results in a loss of ambulation by age ten to eleven years. Early and severe respiratory insufficiency occurs in all individuals, resulting in the need for nocturnal noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BiPAP) by age 11 years. Intermediate COL6-RD is characterized by independent ambulation past age 11 years and respiratory insufficiency that is later in onset than in UCMD and results in the need for NIV in the form of BiPAP by the late teens to early 20s. In contrast to individuals with Bethlem muscular dystrophy, those with intermediate COL6-RD typically do not achieve the ability to run, jump, or climb stairs without use of a railing.</Attribute>
                <XRef ID="NBK1503" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301676</ID>
                <ID Source="BookShelf">NBK1503</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="610" DB="Orphanet" />
              <XRef ID="CN029274" DB="MedGen" />
              <XRef ID="MONDO:0024530" DB="MONDO" />
              <XRef Type="MIM" ID="158810" DB="OMIM" />
            </Trait>
            <Trait ID="33491" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dystonia 27</ElementValue>
                <XRef ID="MONDO:0014627" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DYT27</ElementValue>
                <XRef Type="MIM" ID="616411" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17819" />
                <XRef ID="17819" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="464440" DB="Orphanet" />
              <XRef ID="C4225336" DB="MedGen" />
              <XRef ID="MONDO:0014627" DB="MONDO" />
              <XRef Type="MIM" ID="616411" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1099137" SubmissionDate="2017-01-23" DateLastUpdated="2017-04-23" DateCreated="2017-04-23">
        <ClinVarSubmissionID localKey="NM_004369.3:c.7669-2delA|OMIM:616411;254090;158810" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000536777" DateUpdated="2017-04-23" DateCreated="2017-04-23" Type="SCV" Version="1" SubmitterName="Division of Human Genetics, Children's Hospital of Philadelphia" OrgID="505472" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-02-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL6A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004369.3:c.7669-2delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616411" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="254090" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="158810" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-PediSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB2336590</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8796606" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="39222828|COL6A3-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004712028" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The COL6A3 c.7669-2delA variant is predicted to result in a deletion affecting a canonical splice site. This variant has been reported in the compound heterozygous state in an individual with Bethlem myopathy (Table S1, Sframeli et al. 2017. PubMed ID: 28688748). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Variants that impact the splice acceptor site are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL6A3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004369.3:c.7669-2delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COL6A3-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1099137" TraitType="Disease" MappingType="XRef" MappingValue="254090" MappingRef="OMIM">
        <MedGen CUI="C0410179" Name="Ullrich congenital muscular dystrophy 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1099137" TraitType="Disease" MappingType="XRef" MappingValue="158810" MappingRef="OMIM">
        <MedGen CUI="CN029274" Name="Bethlem myopathy 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8796606" TraitType="Disease" MappingType="Name" MappingValue="COL6A3-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="COL6A3-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1099137" TraitType="Disease" MappingType="XRef" MappingValue="616411" MappingRef="OMIM">
        <MedGen CUI="C4225336" Name="Dystonia 27" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

